Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice.
<a href="https://www.fiercebiotech.com/medtech/dexcom-hit-fda-class1-recall-its-continuous-glucose-monitoring-system-app" hreflang="en">Dexcom hit by FDA Class I recall for its continuous glucose monitoring system app</a>
FierceBiotech | | Ben Adams
Topics: blood-cancer